881 related articles for article (PubMed ID: 31906769)
1. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
3. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
Yan J; Xu H
Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
5. MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.
Jiang F; Zhao W; Zhou L; Liu Z; Li W; Yu D
Int J Mol Sci; 2014 Dec; 15(12):22128-41. PubMed ID: 25474084
[TBL] [Abstract][Full Text] [Related]
6. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
7. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
[TBL] [Abstract][Full Text] [Related]
8. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
Wang Y; Jiang Y; Chen L
J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
[TBL] [Abstract][Full Text] [Related]
9. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
Wang L; Liu H
Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
[TBL] [Abstract][Full Text] [Related]
10. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
11. MiR-149-5p regulates cisplatin chemosensitivity, cell growth, and metastasis of oral squamous cell carcinoma cells by targeting TGFβ2.
Luo K; He J; Yu D; Açil Y
Int J Clin Exp Pathol; 2019; 12(10):3728-3739. PubMed ID: 31933761
[TBL] [Abstract][Full Text] [Related]
12. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
14. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
15. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
Wang K; Jin J; Ma T; Zhai H
J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
[TBL] [Abstract][Full Text] [Related]
16. miR-21 inhibitor sensitizes human OSCC cells to cisplatin.
Wang W; Songlin P; Sun Y; Zhang B; Jinhui W
Mol Biol Rep; 2012 May; 39(5):5481-5. PubMed ID: 22249446
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
20. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
